Burney Co. Reduces Stake in DaVita Inc. (NYSE:DVA)

Burney Co. lowered its stake in DaVita Inc. (NYSE:DVA) by 16.2% in the 4th quarter, HoldingsChannel reports. The fund owned 1,391 shares of the company’s stock after selling 268 shares during the period. Burney Co.’s holdings in DaVita were worth $208,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC purchased a new position in DaVita in the third quarter worth about $25,000. Blue Trust Inc. grew its position in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares in the last quarter. Quarry LP purchased a new position in DaVita in the third quarter worth about $60,000. Versant Capital Management Inc grew its position in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Point72 Hong Kong Ltd purchased a new position in DaVita in the second quarter worth about $68,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on DVA. Truist Financial lifted their price target on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $161.80.

DaVita Stock Performance

DaVita stock opened at $166.28 on Friday. The company has a 50 day moving average price of $157.11 and a 200-day moving average price of $152.81. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita Inc. has a fifty-two week low of $103.40 and a fifty-two week high of $169.51. The company has a market capitalization of $13.63 billion, a PE ratio of 17.94, a P/E/G ratio of 0.75 and a beta of 0.92.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $2.85 EPS. As a group, equities analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.